Journal of Enzyme Inhibition and Medicinal Chemistry · 2023 · 23 citations · 54 references
PharmacyMedicinal ChemistryPharmacologyComputational Medicinal ChemistryDrug DesignDrug DiscoveryComputational Drug DiscoveryEnzyme InhibitionLigand BindingMolecular ModelingQuantitative Structure-activity RelationshipsVirtual ScreeningCarbonic Anhydrase FunctionCarbonic Anhydrase InhibitorsCarbonic Anhydrase TargetsComputer-aided Drug DiscoveryEnzymatic AssaysEnzyme Inhibitor DiscoveryNovel Antibacterial Drug DiscoveryVirulence Determinants
Vibrio cholerae causes life-threatening infections in low-income countries due to the rise of antibacterial resistance. Innovative pharmacological targets have been investigated and carbonic anhydrases (CAs, EC: 4.2.1.1) encoded by V. cholerae (VchCAs) emerged as a valuable option. Recently, we developed a large library of para- and meta-benzenesulfonamides characterised by moieties with a different flexibility degree as CAs inhibitors. Stopped flow-based enzymatic assays showed strong inhibition of VchαCA for this library, while lower affinity was detected against the other isoforms. In particular, cyclic urea 9c emerged for a nanomolar inhibition of VchαCA (KI = 4.7 nM) and high selectivity with respect to human isoenzymes (SI≥ 90). Computational studies revealed the influence of moiety flexibility on inhibitory activity and isoform selectivity and allowed accurate SARs. However, although VchCAs are involved in the bacterium virulence and not in its survival, we evaluated the antibacterial activity of such compounds, resulting in no direct activity.
54
BLAST+: architecture and applications
Christiam Camacho, George Coulouris, Vahram Avagyan et al. · BMC Bioinformatics · 2009 · 23.2K citations · Full text
Damian Szklarczyk, Katerina Nastou, David Lyon et al. · Nucleic Acids Research · 2020 · 8.6K citations · Full text
UniProt: the Universal Protein Knowledgebase in 2023
Alex Bateman, María Martin, Sandra Orchard et al. · Nucleic Acids Research · 2022 · 7K citations · Full text